Aurinia Pharmaceuticals Inc. diskutieren
Aurinia Pharmaceuticals Inc.
WKN: A1W7D4 / Name: Aurinia Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
6,02 €
-0,70 %
Sell Aurinia Pharmaceuticals Inc.
Buy mit Kursziel 12,0
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Another statement from the pharmaceutical business states that Prostvac, a drug used to treat prostatic acromegaly, will be licensed and marketed by Bristol-Myers Squibb under an exclusive agreement to be established with Bavarian Nordic leadership coaches
.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
This is info is great but it's not easy to understand. @tiny fishing
Sell Aurinia Pharmaceuticals Inc.
Buy mit Kursziel 10,0
Sell mit Kursziel 10,0
Neueste Beiträge
DirectorDealer in Sino AG diskutieren